Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.

Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be attenuated via an action on OC by cilostazol....

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ke Ke, Ali Muhammad Safder, Ok-Joo Sul, Jae-Hee Suh, Yeonsoo Joe, Hun-Taeg Chung, Hye-Seon Choi
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2015-01-01
Serija:	PLoS ONE
Online dostop:	http://europepmc.org/articles/PMC4436362?pdf=render
Oznake:	Označite Brez oznak, prvi označite!